X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2348) 2348
Publication (226) 226
Book / eBook (7) 7
Book Chapter (5) 5
Data Set (2) 2
Book Review (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rectum (1537) 1537
humans (1434) 1434
index medicus (1413) 1413
male (1089) 1089
female (1019) 1019
cancer (624) 624
middle aged (620) 620
medicine (612) 612
research article (606) 606
animals (578) 578
adult (558) 558
science (553) 553
multidisciplinary sciences (543) 543
infectious diseases (513) 513
patients (489) 489
colorectal cancer (476) 476
aged (451) 451
colon (442) 442
oncology (417) 417
research (414) 414
surgery (389) 389
infections (379) 379
risk factors (356) 356
health aspects (351) 351
immunology (316) 316
analysis (314) 314
microbiology (313) 313
medicine and health sciences (312) 312
infection (285) 285
biology and life sciences (284) 284
tumors (280) 280
epidemiology (265) 265
diagnosis (262) 262
studies (262) 262
rectum - virology (261) 261
virology (251) 251
aged, 80 and over (232) 232
colorectal carcinoma (222) 222
medical research (220) 220
intestine (213) 213
rectum - microbiology (213) 213
hospitals (212) 212
care and treatment (209) 209
hiv (207) 207
human immunodeficiency virus--hiv (207) 207
viruses (198) 198
biopsy (193) 193
mucosa (190) 190
biology (186) 186
health risks (186) 186
prevalence (186) 186
bacteria (181) 181
rectum - pathology (181) 181
men (179) 179
prevention (177) 177
gene expression (175) 175
survival (175) 175
young adult (175) 175
retrospective studies (169) 169
usage (168) 168
risk (167) 167
mortality (166) 166
proteins (165) 165
public health (162) 162
polymerase chain reaction (161) 161
adolescent (160) 160
research and analysis methods (158) 158
prognosis (152) 152
genetic aspects (150) 150
pathology (150) 150
cancers and neoplasms (149) 149
digestive system (148) 148
anatomy (147) 147
cancer therapies (147) 147
gastroenterology and hepatology (143) 143
treatment outcome (143) 143
deoxyribonucleic acid--dna (142) 142
sexually transmitted diseases (142) 142
dna (141) 141
sex (139) 139
genes (137) 137
metastasis (137) 137
colon cancer (136) 136
antibiotics (135) 135
chemotherapy (135) 135
disease (135) 135
regression analysis (135) 135
radiation therapy (133) 133
statistical analysis (133) 133
gastrointestinal tract (129) 129
laboratories (129) 129
mice (127) 127
confidence intervals (126) 126
disease transmission (126) 126
prospective studies (126) 126
medical prognosis (125) 125
health risk assessment (124) 124
inflammation (124) 124
clinical trials (121) 121
pediatrics (121) 121
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2347) 2347
Chinese (10) 10
French (2) 2
German (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science Translational Medicine, ISSN 1946-6234, 05/2010, Volume 2, Issue 32, pp. 32ra36 - ra36
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140670
Journal Article
Cancer, ISSN 0008-543X, 01/2018, Volume 124, Issue 1, pp. 203 - 211
Five‐year relative survival is highest for patients who have vulvar and anal cancers and lowest for those who have penile and oropharyngeal cancers compared... 
human papillomavirus (HPV) cancer | relative survival | HPV‐associated cancer | HPV-associated cancer | UNITED-STATES | HEAD | POPULATION | PREVALENCE | NECK-CANCER | ONCOLOGY | OROPHARYNGEAL CANCER | SQUAMOUS-CELL CARCINOMA | SURVEILLANCE | BURDEN | INCIDENCE TRENDS | Head and Neck Neoplasms - virology | Age Factors | United States | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | African Americans | Anus Neoplasms - virology | Male | Incidence | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Rectal Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Uterine Cervical Neoplasms - mortality | Vulvar Neoplasms - mortality | Databases, Factual | Penile Neoplasms - mortality | Penile Neoplasms - virology | Papillomavirus Infections - epidemiology | Vulvar Neoplasms - virology | European Continental Ancestry Group | Survival Rate | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Rectal Neoplasms - mortality | Vaginal Neoplasms - mortality | Anus Neoplasms - mortality | Uterine Cervical Neoplasms - virology | Papillomaviridae | Head and Neck Neoplasms - mortality | Prevention | Cancer patients | Diagnosis | Anal cancer | Cervical cancer | Squamous cell carcinoma | Invasiveness | Vaccination | Sex | Vagina | Vaccines | Cervix | Patients | Survival | Public domain | Screening | Demographics | Human papillomavirus | Penis | Race | Rectum | Cervical carcinoma | Age | Cancer
Journal Article
Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 1
Definition of the key parameters mediating effective antibody blocking of HIV-1 acquisition within mucosal tissue may prove critical to effective vaccine... 
Mucosal immunity | HIV vaccines | Human immunodeficiency virus | Neutralizing antibodies | Nonneutralizing antibodies | 2F5 | VIRUS | nonneutralizing antibodies | FC-GAMMA RECEPTORS | DENDRITIC CELLS | PROTECTION | neutralizing antibodies | VIROLOGY | human immunodeficiency virus | EPITOPE SPECIFICITY | MONOCLONAL-ANTIBODIES | TYPE-1 | CYTOTOXICITY | BINDING | mucosal immunity | HIV Infections - prevention & control | Antibodies, Monoclonal - biosynthesis | Dendritic Cells - immunology | Humans | Male | Leukocytes, Mononuclear - virology | Rectum - virology | Immunity, Mucosal - drug effects | HIV Infections - immunology | Receptors, IgG - genetics | HIV-1 - growth & development | Rectum - drug effects | HIV Antibodies - biosynthesis | Mucous Membrane - drug effects | Gene Expression | Leukocytes, Mononuclear - drug effects | Cervix Uteri - virology | Mucous Membrane - virology | Penis - cytology | Antibodies, Monoclonal - pharmacology | HIV Infections - virology | Receptors, IgG - immunology | Rectum - immunology | Rectum - cytology | Models, Biological | Cervix Uteri - immunology | Leukocytes, Mononuclear - cytology | HeLa Cells | Penis - immunology | Penis - virology | Penis - drug effects | Mucous Membrane - cytology | Macrophages - virology | Leukocytes, Mononuclear - immunology | Dendritic Cells - drug effects | Female | Dendritic Cells - virology | HIV Antibodies - pharmacology | Macrophages - immunology | Cervix Uteri - drug effects | HIV-1 - drug effects | Tissue Culture Techniques | Antibodies, Neutralizing - pharmacology | Macrophages - cytology | HIV-1 - immunology | Animals | Mucous Membrane - immunology | Antibodies, Neutralizing - biosynthesis | Macrophages - drug effects | Dendritic Cells - cytology | Cervix Uteri - cytology
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0132942
Studies have shown that the transmission of HIV is most likely to occur via rectal or vaginal routes, and rarely through oral exposure. However, the mechanisms... 
TRANSMISSION | PROTEIN | DENDRITIC CELLS | EPITHELIUM | DC-SIGN | MULTIDISCIPLINARY SCIENCES | RECEPTOR | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | GENITAL-TRACT | Antigen-Presenting Cells - metabolism | Cervix Uteri - metabolism | Epithelial Cells - metabolism | Cervix Uteri - virology | Epithelium - metabolism | Mucous Membrane - virology | Humans | Rectum - metabolism | CD4-Positive T-Lymphocytes - metabolism | Receptors, Cell Surface - metabolism | Rectum - virology | Antigen-Presenting Cells - virology | Colon, Sigmoid - metabolism | Epithelium - virology | Mucous Membrane - metabolism | Colon, Sigmoid - virology | Epithelial Cells - virology | Vagina - virology | Female | HIV - metabolism | HIV Infections - transmission | Vagina - metabolism | CD4-Positive T-Lymphocytes - virology | HIV Infections - metabolism | Immunohistochemistry | Laboratories | Epithelial cells | Mucosa | Viruses | Infections | Lymphocytes T | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Colon | Binding | Squamous cells | Antigens | Dendritic cells | Ducts | Vagina | Salivary gland | Glycoproteins | CD3 antigen | Dentistry | Epithelium | Molecular chains | CD4 antigen | Medicine | Pathology | CD16 antigen | Infectious diseases | Disease transmission | Antigen-presenting cells | Rectum | Saliva | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2010, Volume 5, Issue 2, p. e9310
Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 infection but has no published data regarding... 
TOPICAL MICROBICIDES | SOUTH-AFRICA | MULTIDISCIPLINARY SCIENCES | FEMALE SEX WORKERS | CLINICAL-TRIALS | NONOXYNOL-9 VAGINAL GEL | DOUBLE-BLIND | NEISSERIA-GONORRHOEAE | RECTAL TRANSMISSION | EXPLANT CULTURE | PLACEBO-CONTROLLED TRIAL | Anti-HIV Agents - pharmacology | Colon - cytology | Humans | Colon - drug effects | Leukocytes, Mononuclear - virology | Rectum - virology | Tenofovir | HIV-1 - growth & development | Rectum - drug effects | Female | Colon - virology | Drug Evaluation, Preclinical | Caco-2 Cells | Cervix Uteri - drug effects | Cell Survival - drug effects | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Cervix Uteri - virology | Gels | HIV-1 - drug effects | Tissue Culture Techniques | Cells, Cultured | Adenine - pharmacology | Organophosphonates - pharmacology | Rectum - cytology | Leukocytes, Mononuclear - cytology | Cervix Uteri - cytology | Infection | Medical research | Algorithms | Microbiota (Symbiotic organisms) | Analysis | Medicine, Experimental | Permeability | HIV (Viruses) | Health aspects | Enzyme-linked immunosorbent assay | Viscosity | Immunohistochemistry | Epithelial cells | Prophylaxis | Clinical trials | Infections | Tissues | Prevention | Genital microflora | Microbicides | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Safety | Explants | Effectiveness | Computer simulation | Vagina | Cultures | Data processing | Flora | Condoms | Osmotic pressure | Viability | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 512, Issue 1, pp. 74 - 77
The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear... 
LATENT INFECTION | REPLICATION | INITIATION | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | VACCINE | PREVENTION | DYNAMICS | IMMUNODEFICIENCY VIRUS-INFECTION | DEPENDS | HIV-1 INFECTION | DNA, Viral - biosynthesis | Macaca mulatta - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | RNA, Viral - blood | Rectum - virology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Proviruses - genetics | Time Factors | Treatment Failure | Female | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Virus Replication - drug effects | Anti-Retroviral Agents - therapeutic use | Anti-Retroviral Agents - pharmacology | Viremia - drug therapy | Simian Immunodeficiency Virus - physiology | DNA, Viral - blood | Carrier State - virology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | Viremia - virology | Anti-Retroviral Agents - administration & dosage | Carrier State - drug therapy | Kinetics | Viral Load - drug effects | Simian Immunodeficiency Virus - drug effects | Physiological aspects | Simian immunodeficiency virus | Virulence (Microbiology) | Studies | Antiretroviral drugs | Lymphocytes | Human immunodeficiency virus--HIV | Infections | Monkeys & apes | Deoxyribonucleic acid--DNA
Journal Article